
A new issue of the online weekly of The Scripps Research Institute, News&Views, is now available at http://www.scripps.edu/newsandviews
In this week's issue:
	Letter from the President Michael A. Marletta, president and CEO of The Scripps Research Institute, sends his holiday greetings and reflects on the institute’s accomplishments in 2013.
	Study Finds Emerging Bird Flu Strain Is Still Poorly Adapted for Infecting Humans Despite initial studies to the contrary, the avian influenza virus H7N9 is still mainly adapted for infecting birds, not humans.
	Compound Dramatically Reduces Joint Inflammation The new drug candidate from the Griffin lab could provide doctors with additional treatment options for patients with rheumatoid arthritis who do not respond well to current therapies.
	Michael Marletta Elected Fellow of National Academy of Inventors; Multiple Sclerosis Drug Discovered at TSRI Advances to Phase 3 Trials; Peter Schultz Named AAAS Fellow; Matthew Disney Wins the ACS David Robertson Award